A clinical statistics clipboard with a bar chart and marigold male symbol on navy paper
eating-disordersclinical-assessmentscreeningmendocumentation

Male Eating Disorder Statistics: Cite and Screen

Photo of Marcus Reilly
Marcus Reilly Practice Operations Editor 10 min read
Outline
FigureValueSource and population
Lifetime AN, men0.12%NESARC-III US adults, 2012-2013
Lifetime BN, men0.08%Same NESARC-III sample
Lifetime BED, men0.42%Same NESARC-III sample
Lifetime AN / BN / BED, men0.3% / 0.5% / 2.0%NCS-R US adults, 2001-2003
Lifetime any ED, men2.2% (0.8-6.5%)Galmiche 2019 weighted mean
Male share of AN cases~25% vs ~8%NCS-R 2007 vs NESARC-III 2018
Probable muscle dysmorphia2.8%Ganson 2025, ages 15-35, CA/US
Muscularity-oriented DE21.9% of young menNagata 2019 Add Health follow-up
SCOFF pooled sensitivity0.86; lower with more menKutz 2020, 25 validation studies
SCOFF evidence in menFew studies; I statementUSPSTF 2022, ages 10+

Educational content for licensed therapists, not clinical or legal advice. Cite the survey, year, and diagnosis. A figure from one population is not a universal male rate. Adapt every screen to the person in front of you.

A man scores 0 on the SCOFF. He trains twice a day, skips carbs after 4 p.m., and uses a testosterone ester he bought online. You could write “no eating-disorder concerns” and move on. That note would match a thinness screen. It would not match male eating disorder statistics.

Cite male eating disorder statistics with the survey, year, and diagnosis attached. Then screen for what that study never asked.

Lifetime prevalence by diagnosis

Udo and Grilo (2018) applied DSM-5 rules in NESARC-III, a nationally representative US adult sample of 36,309 interviews from 2012 to 2013. Lifetime anorexia nervosa was 0.12% in men and 1.42% in women. Lifetime bulimia nervosa was 0.08% in men and 0.46% in women. Lifetime binge-eating disorder was 0.42% in men and 1.25% in women. Those are the figures to cite when someone asks for current US adult male eating disorder statistics.

Hudson, Hiripi, Pope, and Kessler (2007) used DSM-IV in the National Comorbidity Survey Replication (household sample, 2001 to 2003). Lifetime anorexia nervosa was 0.3% in men and 0.9% in women. Lifetime bulimia nervosa was 0.5% in men and 1.5% in women. Lifetime binge-eating disorder was 2.0% in men and 3.5% in women. Those numbers are still in circulation. They are a different instrument, a different decade, and a different sample. Do not average them with NESARC-III.

Galmiche, Déchelotte, Lambert, and Tavolacci (2019) pooled studies published from 2000 to 2018. Weighted lifetime means for any accurately diagnosed eating disorder were 2.2% in men (range 0.8% to 6.5%) and 8.4% in women (range 3.3% to 18.6%). That is a worldwide weighted mean for any accurately diagnosed eating disorder, not a US census and not a diagnosis-specific rate. Use it when you need a range. Do not write “2.2% of men” in the chart.

For adolescents, Swanson, Crow, Le Grange, Swendsen, and Merikangas (2011) reported NCS-A lifetime figures of 0.3% anorexia nervosa, 0.5% bulimia nervosa, and 0.8% binge-eating disorder in adolescent males, versus 0.3%, 1.3%, and 2.3% in adolescent females. Name the age band when you quote them.

Share of cases that are male

The “one in four” line is Hudson 2007 arithmetic, not a law of nature. If you treat the adult population as half men, NCS-R lifetime rates imply men are about 25% of anorexia nervosa cases, 25% of bulimia nervosa cases, and about 36% of binge-eating-disorder cases. NESARC-III lifetime rates imply about 8%, 15%, and 25%. Same country, different survey, different share.

Do not tell a referring physician that eating disorders affect males more often than females. No community survey in this set supports that. What they do support is that binge-eating disorder is the diagnosis where the male share is largest, and that a clinic roster that is 5% to 10% men is not a prevalence study. Strother, Lemberg, Stanford, and Turberville (2012) described men as underdiagnosed, undertreated, and misunderstood. That is a clinical pattern, not a rate you can paste.

When a colleague wants the male eating disorder prevalence number, give NESARC-III by diagnosis, then the survey that produced the share they are about to quote.

Muscle dysmorphia is not a rare add-on

Pope, Gruber, Choi, Olivardia, and Phillips (1997) named muscle dysmorphia as a form of body dysmorphic disorder: a preoccupation that one’s body is too small or not muscular enough, with eating, exercise, and often substance use organized around that fear. You still have to ask, because the food rules look like an eating disorder and a thinness-only screen may miss that presentation.

Ganson, Mitchison, Rodgers, Murray, Testa, and Nagata (2025) found probable muscle dysmorphia in 2.8% of a sample of boys and men aged 15 to 35 in Canada and the United States. Mitchison and colleagues (2022) found 2.2% of Australian high-school boys met muscle-dysmorphia criteria in the EveryBODY study. Those are those samples. Do not write “3% of men have muscle dysmorphia” as a US rate.

Nagata, Murray, Bibbins-Domingo, Garber, Mitchison, and Griffiths (2019) followed the National Longitudinal Study of Adolescent to Adult Health. At ages 18 to 26, 21.9% of young men versus 4.5% of young women reported any muscularity-oriented disordered eating (eating more or different foods to bulk, supplements to gain, or anabolic-androgenic steroids). Trying to gain weight or build muscle was 27.5% in young men and 4.9% in young women. Steroid use in that follow-up was 2.8% in young men. Those are behaviors, not diagnoses. They are why a man who is not underweight still belongs in an eating-disorder interview.

Murray, Nagata, Griffiths, Calzo, Brown, Mitchison, Blashill, and others (2017) reviewed male eating disorders as an assessment problem: muscularity-oriented eating, supplement and steroid use, and body-image fear that does not map onto “fear of fat” items. If the presentation is sport plus cutting, stay on eating disorders in athletes for the REDs overlay. The statistics you cite still come from here.

Screens that under-detect men

Morgan, Reid, and Lacey built the SCOFF on young women with anorexia nervosa and bulimia nervosa. Kutz, Marsh, Gunderson, Maguen, and Masheb (2020) pooled 25 validation studies: sensitivity 0.86 (95% CI 0.78 to 0.91), specificity 0.83 (95% CI 0.77 to 0.88). Sensitivity was highest in case-control samples of young women with anorexia nervosa and bulimia nervosa. Sensitivity fell in studies that included more men, binge-eating disorder, or large community samples.

The 2022 USPSTF review found that most screening-test accuracy studies assessed adult females, while few evaluated males, adolescents, or other populations. The USPSTF concluded that evidence was insufficient to assess the balance of benefits and harms of routine screening. Male eating disorder statistics do not tell you to skip SCOFF. They tell you a score of 0 is not clearance.

ToolBuilt aroundWhat it misses in menWhat you do instead
SCOFFAN/BN in young womenMuscularity, BED, mixed-sex samplesInterview; do not treat 0 as clearance
EAT-26Thinness and dieting itemsBulk, extra protein, steroid useAdd muscularity questions
EDE-Q shape/weightFear of fat, desire to lose”Too small” fear, gain-phase rulesAsk the feared body, not only BMI
PHQ-9 / vitals onlyMood or medical flagsCompensatory extra trainingAsk rest days and unplanned sessions

Scoring, cutoffs, and what a positive flag buys you live on the SCOFF questionnaire page. Choosing among SCOFF, ESP, EAT-26, EDE-Q, BES, and EDE lives on eating disorder assessment. Technique selection after you have named the problem lives on eating disorder therapy techniques. Stay here for the figures and the questions the figures imply.

Download the mental health rating scales guide to compare measures and document why a thinness-only screen was not enough.

Free PDF: Scales for Mental Health

A printable clinician selection matrix for brief outpatient measures: use case, access, cadence, stop rules, and one charting stem.

  • Six-row matrix: depression, anxiety, mixed distress, trauma clusters, alliance, functioning
  • Clinician card for purpose, fit, stop conditions, sort, and the documentation prompt
  • Worked example of one fictional outpatient adult, initials only

Free. We'll email the PDF link right away and add you to the therapist toolkit, sent every two weeks. Unsubscribe any time.

Questions to add at intake

Ask yesterday, not a philosophy. Ask the rest day. Ask what is off-limits when the goal is size, not shrinkage.

Copy-ready fields for the next man who “does not look like an eating disorder”:

Write the observations that would let a covering clinician see why a thinness score of 0 was not the end of the assessment. Name the male eating disorder statistics you cited so they can re-cite the same survey.

Keep the fuller intake between sessions

Draft notes that carry muscularity questions, screen results, and medical follow-up into the next check-in.

Draft the intake note
  • No credit card
Intake review
Fictional · First assessment

Client said

A rest day makes me feel like I am getting smaller.

Draft for your review

Intake draft: Screen limits and medical loop are ready to check.

Add the next check-in →

References

  • Galmiche, M., Déchelotte, P., Lambert, G., & Tavolacci, M. P. (2019). Prevalence of eating disorders over the 2000-2018 period: A systematic literature review. American Journal of Clinical Nutrition, 109(5), 1402-1413. DOI
  • Ganson, K. T., Mitchison, D., Rodgers, R. F., Murray, S. B., Testa, A., & Nagata, J. M. (2025). Prevalence and correlates of muscle dysmorphia in a sample of boys and men in Canada and the United States. Journal of Eating Disorders, 13, 47. DOI
  • Hudson, J. I., Hiripi, E., Pope, H. G., Jr., & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61(3), 348-358. DOI
  • Kutz, A. M., Marsh, A. G., Gunderson, C. G., Maguen, S., & Masheb, R. M. (2020). Eating disorder screening: A systematic review and meta-analysis of diagnostic test characteristics of the SCOFF. Journal of General Internal Medicine, 35(3), 885-893. DOI
  • Mitchison, D., Mond, J., Griffiths, S., Hay, P., Nagata, J. M., Bussey, K., Trompeter, N., Lonergan, A., & Murray, S. B. (2022). Prevalence of muscle dysmorphia in adolescents: Findings from the EveryBODY study. Psychological Medicine, 52(14), 3142-3149. DOI
  • Murray, S. B., Nagata, J. M., Griffiths, S., Calzo, J. P., Brown, T. A., Mitchison, D., Blashill, A. J., & Mond, J. M. (2017). The enigma of male eating disorders: A critical review and synthesis. Clinical Psychology Review, 57, 1-11. DOI
  • Nagata, J. M., Murray, S. B., Bibbins-Domingo, K., Garber, A. K., Mitchison, D., & Griffiths, S. (2019). Predictors of muscularity-oriented disordered eating behaviors in U.S. young adults: A prospective cohort study. International Journal of Eating Disorders, 52(12), 1380-1388. DOI
  • Pope, H. G., Jr., Gruber, A. J., Choi, P., Olivardia, R., & Phillips, K. A. (1997). Muscle dysmorphia: An underrecognized form of body dysmorphic disorder. Psychosomatics, 38(6), 548-557. PubMed
  • Strother, E., Lemberg, R., Stanford, S. C., & Turberville, D. (2012). Eating disorders in men: Underdiagnosed, undertreated, and misunderstood. Eating Disorders, 20(5), 346-355. DOI
  • Swanson, S. A., Crow, S. J., Le Grange, D., Swendsen, J., & Merikangas, K. R. (2011). Prevalence and correlates of eating disorders in adolescents: Results from the National Comorbidity Survey Replication Adolescent Supplement. Archives of General Psychiatry, 68(7), 714-723. DOI
  • Udo, T., & Grilo, C. M. (2018). Prevalence and correlates of DSM-5-defined eating disorders in a nationally representative sample of U.S. adults. Biological Psychiatry, 84(5), 345-354. DOI
  • US Preventive Services Task Force. (2022). Screening for eating disorders in adolescents and adults: US Preventive Services Task Force recommendation statement. JAMA, 327(11), 1061-1067. DOI

Free PDF: Scales for Mental Health

A printable clinician selection matrix for brief outpatient measures: use case, access, cadence, stop rules, and one charting stem.

  • Six-row matrix: depression, anxiety, mixed distress, trauma clusters, alliance, functioning
  • Clinician card for purpose, fit, stop conditions, sort, and the documentation prompt
  • Worked example of one fictional outpatient adult, initials only

Free. We'll email the PDF link right away and add you to the therapist toolkit, sent every two weeks. Unsubscribe any time.

Ready to transform your practice?

Join 10,000+ therapists using Emosapien.